SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
POMILIO LUKE A

(Last) (First) (Middle)
C/O CONMED CORP
525 FRENCH ROAD

(Street)
UTICA NY 13502-5994

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CONMED CORP [ CNMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Finance & CFO
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/01/2015 M 800 A $0 25,258 D
Common Stock 06/01/2015 F 289 D $55.7 24,969 D
Common Stock 06/01/2015 M 800 A $0 25,769 D
Common Stock 06/01/2015 F 289 D $55.7 25,480 D
Common Stock 06/01/2015 M 1,000 A $0 26,480 D
Common Stock 06/01/2015 F 361 D $55.7 26,119 D
Common Stock 06/01/2015 M 800 A $0 26,919 D
Common Stock 06/01/2015 F 289 D $55.7 26,630 D
Common Stock 06/01/2015 M 1,000 A $0 27,630 D
Common Stock 06/01/2015 F 361 D $55.7 27,269 D
Common Stock 06/01/2015 M 1,000 A $0 28,269 D
Common Stock 06/01/2015 F 361 D $55.7 27,908 D
Common Stock 06/01/2015 M 650 A $0 28,558 D
Common Stock 06/01/2015 F 235 D $55.7 28,323 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Rsus (restricted Stock Units) $0 06/01/2015 M 800 (1) 06/01/2020 Common Stock 800 $0 0 D
Rsus (restricted Stock Units) $0 06/01/2015 M 800 (1) 06/01/2021 Common Stock 800 $0 800 D
Rsus (restricted Stock Units) $0 06/01/2015 M 1,000 (2) 07/29/2021 Common Stock 1,000 $0 1,000 D
Rsus (restricted Stock Units) $0 06/01/2015 M 800 (1) 06/01/2022 Common Stock 800 $0 1,600 D
Rsus (restricted Stock Units) $0 06/01/2015 M 1,000 (1) 06/01/2023 Common Stock 1,000 $0 3,000 D
Rsus (restricted Stock Units) $0 06/01/2015 M 1,000 (3) 07/26/2023 Common Stock 1,000 $0 3,000 D
Rsus (restricted Stock Units) $0 06/01/2015 M 650 (1) 06/01/2024 Common Stock 650 $0 2,600 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a five year period with the first 20% of the RSU's vesting June 1, 2012.
3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a five year period with the first 20% of the RSU's vesting June 1, 2014.
Daniel S. Jonas for Luke A. Pomilio by Power of Attorney 06/03/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.